Taytulla birth control pills recalled; packaging error could lead to unintended pregnancy

Adjust Comment Print

Allergan, which attributed the issue to a packing error, said the four inactive pills were incorrectly placed at the start of.

Allergan is voluntarily recalling packs of its birth control pills in the USA because of a packaging error with placebos, increasing the possibility of unintended pregnancy. Allergan is voluntarily recalling all the units in the lot.

More news: Prominent Russian journalist and Putin critic Arkady Babchenko killed in Kyiv

If you've received a sample pack of Taytulla birth control pills from your doctor in recent months, beware: the manufacturer put the placebo pills in the wrong place. Reversing the order may not be evident to new or previous users, which can further increase the chance of taking the capsules out of sequence.

The company said their was a packaging error, according to a news release posted on the Food and Drug Administration's website.

More news: Sask. reacts to federal government's purchase of Trans Mountain pipeline

The pill pack is a 28 count blister card that has 24 "active" pink capsules with hormones in them, which should be taken for the first 24 days, followed by four maroon capsules without hormones in them to be taken for the next four days. May 2019. Consumers who have the sample pack product with the associated lot number should notify their physician to arrange a return.

Allegan is notifying customers by recall letter and is arranging for the return of the sample packs.

More news: Papua New Guinea to ban Facebook for a month

Anyone with affected packs are asked to call Allergen at 800-678-1605 between 8 a.m. and 8 p.m. Monday through Friday.

Comments